These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1596743

  • 1. Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.
    Vécsei L, Miller J, MacGarvey U, Beal MF.
    Brain Res Bull; 1992 Feb; 28(2):233-8. PubMed ID: 1596743
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K.
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.
    Nozaki K, Beal MF.
    J Cereb Blood Flow Metab; 1992 May; 12(3):400-7. PubMed ID: 1569135
    [Abstract] [Full Text] [Related]

  • 6. The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.
    Miller JM, MacGarvey U, Beal MF.
    Neurosci Lett; 1992 Oct 26; 146(1):115-8. PubMed ID: 1475044
    [Abstract] [Full Text] [Related]

  • 7. Carbamazepine enhances brain production of kynurenic acid in vitro.
    Kocki T, Kocki J, Wielosz M, Turski WA, Urbanska EM.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):325-6. PubMed ID: 15364012
    [Abstract] [Full Text] [Related]

  • 8. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC, Harris EW, Ray R, Stagnitto ML, Schmiesing RJ.
    Arch Int Pharmacodyn Ther; 1992 Sep 13; 317():16-34. PubMed ID: 1456842
    [Abstract] [Full Text] [Related]

  • 9. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
    Singh L, Oles RJ, Tricklebank MD.
    Br J Pharmacol; 1990 Feb 13; 99(2):285-8. PubMed ID: 1691674
    [Abstract] [Full Text] [Related]

  • 10. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.
    Swartz KJ, During MJ, Freese A, Beal MF.
    J Neurosci; 1990 Sep 13; 10(9):2965-73. PubMed ID: 2168940
    [Abstract] [Full Text] [Related]

  • 11. A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study : special issue related to kynurenine.
    Demeter I, Nagy K, Gellért L, Vécsei L, Fülöp F, Toldi J.
    J Neural Transm (Vienna); 2012 Feb 13; 119(2):151-4. PubMed ID: 22231843
    [Abstract] [Full Text] [Related]

  • 12. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
    Cosi C, Mannaioni G, Cozzi A, Carlà V, Sili M, Cavone L, Maratea D, Moroni F.
    Neuropharmacology; 2011 Jun 13; 60(7-8):1227-31. PubMed ID: 21110987
    [Abstract] [Full Text] [Related]

  • 13. Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids.
    Lapin IP.
    J Neural Transm; 1983 Jun 13; 56(2-3):177-85. PubMed ID: 6864208
    [Abstract] [Full Text] [Related]

  • 14. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
    Miranda AF, Sutton MA, Beninger RJ, Jhamandas K, Boegman RJ.
    Neurosci Lett; 1999 Mar 05; 262(2):81-4. PubMed ID: 10203236
    [Abstract] [Full Text] [Related]

  • 15. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
    Rozsa E, Robotka H, Nagy D, Farkas T, Sas K, Vecsei L, Toldi J.
    Brain Res Bull; 2008 Jul 30; 76(5):474-9. PubMed ID: 18534254
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D, Pérez-De La Cruz V, Villeda-Hernández J, Carrillo-Mora P, González-Herrera IG, García E, Colín-Barenque L, Pedraza-Chaverrí J, Santamaría A.
    Neurotoxicol Teratol; 2011 Jul 30; 33(2):303-12. PubMed ID: 20933078
    [Abstract] [Full Text] [Related]

  • 17. The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain.
    Kabuto H, Yokoi I, Takei M, Kurimoto T, Mori A.
    Neurochem Res; 1994 Apr 30; 19(4):463-7. PubMed ID: 7520538
    [Abstract] [Full Text] [Related]

  • 18. [Interaction of kynurenine and diazepam].
    Lapin IP.
    Biull Eksp Biol Med; 1984 Aug 30; 98(8):206-9. PubMed ID: 6466859
    [Abstract] [Full Text] [Related]

  • 19. Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity.
    Connick JH, Heywood GC, Sills GJ, Thompson GG, Brodie MJ, Stone TW.
    Gen Pharmacol; 1992 Mar 30; 23(2):235-9. PubMed ID: 1639238
    [Abstract] [Full Text] [Related]

  • 20. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.
    Urenjak J, Obrenovitch TP.
    J Neurochem; 2000 Dec 30; 75(6):2427-33. PubMed ID: 11080194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.